Analysts expect Bioventus Inc. to report revenue of 171.46 M for Q4 26, against a range of 163.49 M to 179.43 M. The most recent reported quarter, Q3 26, came in at 142.44 M, a 2.0% miss against the 145.30 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 153.64 M | 123.88 M | 147.66 M | 138.65 M | 157.90 M | 132.09 M | 153.21 M | 142.44 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 155.67 M | 122.62 M | 154.21 M | 152.02 M | 159.53 M | 144.52 M | 179.10 M | 152.62 M | 179.43 M | 149.33 M | 166.16 M | 156.00 M | 180.25 M | 163.66 M | 188.46 M | 167.81 M | |||||||||
| Low Estimate | 143.76 M | 109.23 M | 128.75 M | 134.02 M | 135.55 M | 132.02 M | 147.49 M | 137.97 M | 163.49 M | 123.31 M | 136.84 M | 140.57 M | 160.78 M | 144.87 M | 176.30 M | 141.40 M | |||||||||
| Consensus Estimate | 149.72 M | 115.92 M | 141.48 M | 143.02 M | 147.54 M | 138.27 M | 163.30 M | 145.30 M | 171.46 M | 136.32 M | 151.50 M | 148.29 M | 170.51 M | 154.26 M | 182.38 M | 154.61 M |
Analysts expect Bioventus Inc. to report earnings per share of 0.21 for Q4 26, against a range of 0.19 to 0.23. The most recent reported quarter, Q3 26, came in at 0.17, a 13.3% beat against the 0.15 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.15 | 0.08 | 0.21 | 0.15 | 0.24 | 0.15 | 0.22 | 0.17 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.09 | 0.02 | 0.18 | 0.11 | 0.23 | 0.07 | 0.22 | 0.16 | 0.23 | 0.15 | 0.26 | 0.23 | 0.29 | 0.18 | 0.32 | 0.26 | |||||||||
| Low Estimate | 0.07 | 0.02 | 0.14 | 0.09 | 0.19 | 0.07 | 0.20 | 0.14 | 0.19 | 0.13 | 0.24 | 0.19 | 0.27 | 0.16 | 0.30 | 0.22 | |||||||||
| Consensus Estimate | 0.08 | 0.02 | 0.16 | 0.10 | 0.21 | 0.07 | 0.21 | 0.15 | 0.21 | 0.14 | 0.25 | 0.21 | 0.28 | 0.17 | 0.31 | 0.24 |
Pull Wall Street consensus for Bioventus Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BVS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BVS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BVS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();